News
Entertainment
Science & Technology
Sport
Business & Money
Life
Culture & Art
Hobbies
9 | Follower
Ysios Capital
26.07.2024
Cytoki announced positive data from a Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of CK-0045, its lead lipidated IL-22 candidate
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy
There is a high unmet medical need in refractory focal epilepsy, and NRTX-1001 potentially represents a breakthrough, with the goal to provide persistent seizure control from a single administration.